Ally Bridge Group (NY) LLC - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 459 filers reported holding REPLIGEN CORP in Q1 2021. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
Ally Bridge Group (NY) LLC ownership history of REPLIGEN CORP
ValueSharesWeighting
Q4 2022$2,062,196
-34.1%
12,180
-27.2%
2.01%
-2.9%
Q3 2022$3,129,000
-83.1%
16,724
-76.1%
2.07%
-68.1%
Q4 2021$18,539,000
-8.4%
70,0000.0%6.48%
+8.9%
Q3 2021$20,229,000
+22.8%
70,000
-15.2%
5.95%
+45.4%
Q2 2021$16,469,000
+2.7%
82,5000.0%4.09%
+33.0%
Q1 2021$16,039,000
+1.5%
82,5000.0%3.08%
+13.5%
Q4 2020$15,809,00082,5002.71%
Other shareholders
REPLIGEN CORP shareholders Q1 2021
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders